|
BCKDHB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.226340E-04 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62458935193399E-12 |
| Stage1-vs-Stage2 |
2.864400E-02 |
| Stage1-vs-Stage3 |
2.622000E-01 |
| Stage1-vs-Stage4 |
2.168100E-02 |
| Stage2-vs-Stage3 |
7.220300E-03 |
| Stage2-vs-Stage4 |
1.037930E-03 |
| Stage3-vs-Stage4 |
2.498400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.41659999997046E-06 |
| Normal-vs-Asian |
1.71185288166953E-12 |
| Caucasian-vs-AfricanAmerican |
1.705390E-01 |
| Caucasian-vs-Asian |
2.964200E-01 |
| AfricanAmerican-vs-Asian |
7.771800E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.64153152077051E-14 |
| Normal-vs-Female |
1.6242562850266E-12 |
| Male-vs-Female |
6.337600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62991842245219E-12 |
| Normal-vs-Age(41-60Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(61-80Yrs) |
1.98918659322089E-12 |
| Normal-vs-Age(81-100Yrs) |
5.384700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.364200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.292400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.025400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.538000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.598800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.604200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.508400E-02 |
| Classical-VS-Follicular |
1.60061999999739E-05 |
| Classical-VS-Other |
5.087000E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
6.68600000031105E-07 |
| Tall-VS-Other |
3.380000E-01 |
| Tall-VS-Normal |
1.4432899320127E-15 |
| Follicular-VS-Other |
3.457200E-01 |
| Follicular-VS-Normal |
8.03010000000048E-05 |
| Other-VS-Normal |
2.341900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.29256671611256E-14 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.93730000000492E-05 |
|
|
